Recorlev (levoketoconazole tablets - Xeris) — Cigna
Endogenous Cushing’s Syndrome
Initial criteria
- Patient age ≥ 18 years; AND
- Patient has hypercortisolemia; AND
- Patient meets ONE of the following (i, ii, OR iii): (i) According to the prescriber, the patient is not a candidate for surgery or surgery has not been curative; OR (ii) Patient is awaiting surgery for endogenous Cushing’s syndrome; OR (iii) Patient is awaiting therapeutic response after radiotherapy for endogenous Cushing’s syndrome; AND
- Patient has tried ketoconazole tablets; AND
- Medication is prescribed by or in consultation with an endocrinologist or a physician who specializes in the treatment of endogenous Cushing’s syndrome.
Approval duration
1 year